RENE CATHEY: Open Payments
NPI 1770689630 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 15 payments from 5 companies in 2025. Trend: 2023 $623 · 2024 $589 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $186 |
| Amgen Inc. | 4 | $59 |
| Lilly USA, LLC | 3 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: BREZTRI, FARXIGA, MOUNJARO, GEMTESA, OTEZLA, REPATHA, EVENITY, SHINGRIX.
Industry payments across MS — which companies pay providers there.
